About the Journal

Cardiovascular Diagnostics and Biomarkers (CDB) will focus on the development of biomarkers and diagnostic strategies for cardiovascular diseases. It is intended to attract submissions involving omics-based profiling, point-of-care testing and diagnostic algorithm design. The journal will cater to translational and clinical research that strengthens early disease detection and refines risk stratification. Works of interest include biomarker-driven evaluation tools, diagnostic models and integrative methods combining molecular and imaging-based assessments.

Announcements

Call for Founding Editorial Board Members | Cardiovascular Diagnostics and Biomarkers (CDB)

2026-01-07

We are pleased to announce that the new ”Cardiovascular Diagnostics and Biomarkers” has been launched. The new open-access journal Cardiovascular Diagnostics and Biomarkers (CDB) is now assembling its inaugural editorial board. We seek outstanding scientists, clinicians and industry experts who share our mission: to accelerate the translation of cardiovascular discoveries into next-generation diagnostics and biomarker-guided therapies.

Read more about Call for Founding Editorial Board Members | Cardiovascular Diagnostics and Biomarkers (CDB)